Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intercept names senior VP, medical affairs

This article was originally published in Scrip

Executive Summary

Intercept Pharmaceuticals, a clinical stage biopharmaceutical company developing novel therapeutics to treat chronic underserved liver diseases such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), has appointed Dr Juan Carlos Lopez-Talavera senior vice-president of medical affairs. Dr Lopez-Talavera was most recently head of hepatology R&D and vice-president of medical affairs at AbbVie, where he was responsible for all medical affairs activities supporting the global launch of AbbVie's regimen for the treatment of hepatitis C.

You may also be interested in...



What Does AI Excellence Look Like In Big Pharma?

Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.

Nurturing The Next Generation Of Top Talent

Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative. 

30 Life Sciences Leaders In The Spotlight

In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care. 

Topics

UsernamePublicRestriction

Register

CO180755

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel